Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
University of Erlangen, Erlangen, Bavaria, Germany
Sir Ganga Ram Hospital, New Delhi, Delhi, India
Belfast Health & Social Care Trust, Belfast, United Kingdom
South Eastern Health and Social Trust, Belfast, United Kingdom
University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
Pfizer Korea, Seoul, Korea, Republic of
Massachusetts General Hospital, Boston, Massachusetts, United States
Mansoura University, Mansourah, DK, Egypt
Queen Mary Hospital, Hong Kong, Hong Kong
The University of Hong Kong, Hong Kong, Hong Kong
Larissa University Hospital, Larissa, Greece
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.